Magnetar Financial LLC Cuts Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Magnetar Financial LLC lowered its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 88.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,000 shares of the medical research company’s stock after selling 23,958 shares during the quarter. Magnetar Financial LLC’s holdings in IQVIA were worth $590,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Avior Wealth Management LLC increased its position in shares of IQVIA by 117.6% during the third quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company’s stock worth $38,000 after acquiring an additional 87 shares during the period. Synergy Asset Management LLC purchased a new stake in shares of IQVIA during the fourth quarter worth $33,000. Versant Capital Management Inc increased its position in shares of IQVIA by 46.0% during the fourth quarter. Versant Capital Management Inc now owns 295 shares of the medical research company’s stock worth $58,000 after acquiring an additional 93 shares during the period. SBI Securities Co. Ltd. purchased a new stake in shares of IQVIA during the fourth quarter worth $60,000. Finally, UMB Bank n.a. increased its holdings in IQVIA by 72.8% in the fourth quarter. UMB Bank n.a. now owns 401 shares of the medical research company’s stock valued at $79,000 after buying an additional 169 shares during the last quarter. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Price Performance

Shares of IQV opened at $185.85 on Friday. IQVIA Holdings Inc. has a fifty-two week low of $179.28 and a fifty-two week high of $254.80. The company has a market capitalization of $32.77 billion, a price-to-earnings ratio of 24.78, a price-to-earnings-growth ratio of 1.99 and a beta of 1.50. The firm has a 50-day simple moving average of $194.94 and a 200-day simple moving average of $208.73. The company has a debt-to-equity ratio of 2.12, a quick ratio of 0.84 and a current ratio of 0.84.

IQVIA (NYSE:IQV) last announced its earnings results on Thursday, February 6th. The medical research company reported $2.90 earnings per share for the quarter, missing the consensus estimate of $3.11 by ($0.21). IQVIA had a return on equity of 28.81% and a net margin of 8.91%. On average, equities research analysts anticipate that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently commented on IQV shares. Bank of America dropped their target price on IQVIA from $255.00 to $235.00 and set a “buy” rating on the stock in a report on Friday, December 13th. Citigroup dropped their target price on IQVIA from $225.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. JPMorgan Chase & Co. dropped their target price on IQVIA from $240.00 to $232.00 and set an “overweight” rating on the stock in a report on Tuesday, February 18th. StockNews.com lowered IQVIA from a “buy” rating to a “hold” rating in a report on Wednesday, March 12th. Finally, William Blair reissued an “outperform” rating on shares of IQVIA in a report on Wednesday, December 11th. Five research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $249.05.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.